Countries covered: Asia
Driven by the demand from the downstream products especially paracetamol, para-aminophenol (PAP) of China keeps developing in recent years. As the main PAP producer in the world, the output of PAP in China already comes to about 110,000 tonnes in 2010.
China and India, two largest API producers in the world, supply 80% of the global paracetamol market in 2010, leading Asia to be the largest origin of paracetamol. Meanwhile, the huge population makes it the largest consumption market of the world. Asia consumes 65,400 tonnes of paracetamol-half of the global output of 2010, though part of that is exported in the form of formulation. As the economy develops, Asia market will be more important.
We study the six most populous countries of AP including China, India, Indonesia, Bangladesh, Pakistan and Japan. Based on the potential of the current market, the panorama of Asia paracetamol can be drawn out.
What are the latest production situation in AP and the consumption details of PAP and paracetamol? What is the market change of PAP and paracetamol in 2006-2010? How is the future development of PAP and paracetamol in 2011-2015? All these aspects can be found in this report. In addition, relevant policies and regulations are also covered in this report. This report combines CCM International's expertise in PAP and paracetamol market research.
Key sections of this report:
- PAP production situation in China, 2008-2010
- Import and export situation of PAP in China, 2000-2010
- Detailed description on consumption patterns and various application fields, 2010
- Forecast on PAP supply and demand of in China, 2011-2015
- The paracetamol production details in AP, 2008-2010
- Import and export situation of paracetamol in AP, 2006-2010
- Paracetamol consumption pattern in AP, 2009-2010
- Forecast on paracetamol supply and demand of in China, 2011-2015
- Clients could reap benefits as followed:
- The details of the production, IE and consumption of Chinese PAP
- The influence of Chinese PAP on paracetamol in AP
- The production, IE and consumption situation of targeted AP countries
- The strengths and weaknesses of different regional producers in AP
- The investment environment of paracetamol in AP
- The challenge and opportunity in the AP paracetamol market
|
- Executive summary
- Methodology
- 1 Market environment of major Asia Pacific countries
- 1.1 General situation
- 1.2 Economic situation
- 1.3 Population & age distribution
- 2 PAP and paracetamol market in the world
- 2.1 PAP and paracetamol supply in the world
- 2.2 PAP and paracetamol demand in the world
- 3 Paracetamol and PAP market in Asia Pacific
- 3.1 PAP production in major Asia Pacific countries
- 3.1.1 Overview of PAP supply and demand in Asia Pacific
- 3.1.2 PAP market in China
- 3.1.2.1 China’s PAP production situation, 2006-2010 16
- 3.1.2.2 Key producers in 2011
- 3.1.2.3 Technology development
- 3.1.2.4 Trade situation of PAP in 2010
- 3.1.2.6 Future forecast on PAP supply and demand in China, 2011-2015
- 3.2 Paracetamol market in major Asia Pacific countries
- 3.2.1 Overview of paracetamol supply and demand in Asia Pacific
- 3.2.2 China
- 3.2.2.1 Key policies and regulations
- 3.2.2.2 Production situation, 2006-2010
- 3.2.2.3 Major producers in 2011
- 3.2.2.4 Trade situation of paracetamol in 2010
- 3.2.2.5 Consumption situation of paracetamol in 2010
- 3.2.2.6 Future forecast on supply and demand, 2011-2015
- 3.2.3 India
- 3.2.3.1 Key policies and regulations
- 3.2.3.2 Production situation, 2007-2010
- 3.2.3.3 Major producers in 2011
- 3.2.3.4 Trade situation of paracetamol in 2010
- 3.2.3.5 Consumption situation of paracetamol in 2010
- 3.2.3.6 Future forecast on supply and demand, 2011-2015
- 3.2.4 Bangladesh
- 3.2.4.1 Key policies and regulations
- 3.2.4.2 Production situation, 2006-2010
- 3.2.4.3 Major producers in 2011
- 3.2.4.4 Trade situation of paracetamol in 2010
- 3.2.4.5 Consumption situation of paracetamol in 2010
- 3.2.4.6 Future forecast on supply and demand, 2011-2015
- 3.2.5 Indonesia
- 3.2.5.1 Key policies and regulations
- 3.2.5.2 Production situation
- 3.2.5.3 Trade situation of paracetamol in 2010
- 3.2.5.4 Consumption situation of paracetamol in 2010
- 3.2.5.5 Future forecast on supply and demand, 2011-2015
- 3.2.6 Others
- 3.2.6.1 Japan
- 3.2.6.2 Pakistan
- 4 Conclusions and suggestions
- 5 Company profiles
- 5.10 Shandong Anqiu Lu’an Pharmaceutical Co., Ltd.
- 5.11 Globus Pharmachem Group
- List of tables:
- Table 3.1.2.1-1 PAP production situation in China, 2006-2010
- Table 3.1.2.2-1 List of active PAP producers in China, 2011
- Table 3.1.2.2-2 Capacity and output of Chinese PAP producers, 2008-2010
- Table 3.1.2.3-1 Introduction to PAP production technologies in China, 2011
- Table 3.1.2.3-2 Production situation of Chinese PAP producers in 2010
- Table 3.1.2.3-3 PAP capacity structure by different technologies in China, 2008-2010
- Table 3.1.2.4-1 Export situation of PAP in China, 2000-2010
- Table 3.1.2.4-2 Export volume and price of PAP, 2010
- Table 3.1.2.4-3 Export destinations of Chinese PAP, 2010
- Table 3.1.2.4-4 Export situation of Chinese producers of PAP, 2010
- Table 3.1.2.5-1 Production & consumption of PAP in China in 1993-2010
- Table 3.1.2.5-2 The output and export of paracetamol, 2008-2010
- Table 3.1.2.6-1 Assumptions of the future GDP growth in China, 2011-2015
- Table 3.1.2.6-2 Factors influencing PAP development
- Table 3.1.2.6-3 Historical growth rate of PAP output in China, 2006-2010
- Table 3.2.1-1 Paracetamol production situation in AP, 2009-2010
- Table 3.2.1-2 Paracetamol trade and consumption in AP, 2009-2010
- Table 3.2.2.1-1 Regulations on paracetamol and its related products, 1996-2011
- Table 3.2.2.3-1 Capacity and output of Chinese paracetamol producers, 2008-2010
- Table 3.2.2.4-1 Export situation of Chinese paracetamol, 2000-2010
- Table 3.2.2.4-2 Export destination and volume of Chinese paracetamol, 2001-2010, tonnes
- Table 3.2.2.5-1 Production & consumption of paracetamol in China, 2000-2010
- Table 3.2.2.5-2 The market value of paracetamol in China, 2006-2010
- Table 3.2.2.5-3 List of some major paracetamol-containing preparations in China in 2010
- Table 3.2.2.6-1 Forecast on output of China's paracetamol, 2011-2015
- Table 3.2.2.6-2 Forecast on export of China's paracetamol, 2011-2015
- Table 3.2.2.6-3 Forecast on domestic consumption of China's paracetamol, 2011-2015
- Table 3.2.3.3-1 Capacity and output of Indian paracetamol producers, 2009-2010
- Table 3.2.3.4-1 Export situation of Indian paracetamol, 2006-2010
- Table 3.2.3.5-1 Paracetamol consumption situation in India, 2007-2010, tonnes
- Table 3.2.3.5-2 List of some major paracetamol-containing preparations in India, 2011
- Table 3.2.3.6-1 Forecast on output of Indian paracetamol, 2011-2015
- Table 3.2.3.6-2 Forecast on export of Indian paracetamol, 2011-2015
- Table 3.2.3.6-3 Forecast on Indian import of paracetamol from China, 2011-2015
- Table 3.2.3.6-4 Forecast on domestic consumption of Indian paracetamol, 2011-2015
- Table 3.2.4.2-1 Paracetamol production in Bangaldesh, 2006-2010
- Table 3.2.4.3-1 Paracetamol prodcution information in Bangladesh, 2009-2010
- Table 3.2.4.4-1 Bangladesh PAP import situation from China, 2005-2010
- Table 3.2.4.4-2 Bangladesh paracetamol import situation from China, 2006-2010
- Table 3.2.4.5-1 Bangladesh paracetamol apparent consumption, 2009-2010
- Table 3.2.4.5-2 List of some major paracetamol-containing preparations in Bangladesh, 2011
- Table 3.2.5.2-1 Paracetamol production in Indonesia, 2006-2010
- Table 3.2.5.3-1 Indonesia's PAP import situation from China, 2005-2010
- Table 3.2.5.3-2 Indonesia's paracetamol import situation from China, 2006-2010
- Table 3.2.5.4-1 Total Import volume of paracetamol in Indonesia, 2009-2010, tonnes
- Table 3.2.5.4-2 Indonesia's apparent consumption of paracetamol, 2009-2010
- Table 3.2.5.4-3 List of some major paracetamol-containing preparations in Indonesia, 2011
- Table 3.2.6.1-1 Japan's paracetamol import situation from India and China, 2010
- Table 3.2.6.1-2 List of some major paracetamol-containing preparations in Japan, 2011
- Table 3.2.6.2-1 Capacity and output of paracetamol in Pakistan, 2008-2010, tonnes
- Table 3.2.6.2-2 Pakistan PAP import situation from China, 2008-2010
- Table 3.2.6.2-3 Pakistan paracetamol import situation from China, 2005-2010
- List of figures:
- Figure 2.1-1 Output of PAP in the world, 2006-2010
- Figure 2.1-2 Output of paracetamol in the world, 2006-2010
- Figure 2.1-3 Paracetamol production distribution by output volume in the world, 2010
- Figure 2.2-1 PAP consumption pattern in the world, 2010
- Figure 2.2-2 PAP consumption pattern in China, 2010
- Figure 2.2-3 Paracetamol consumption in the world, 2010
- Figure 3.1.2.4-1 Export volume and price comparison of PAP produced by two different technologies in China, 2000-2010
- Figure 3.1.2.6-1 China's GDP growth, 2006-2010
- Figure 3.1.2.6-2 Forecast on output of China's PAP, 2011-2015
- Figure 3.1.2.6-3 Forecast on domestic consumption of China's PAP, 2011-2015
- Figure 3.1.2.6-4 Forecast on export of China's PAP, 2011-2015
- Figure 3.2.2.2-1 Capacity and output of Chinese paracetamol, 2005-2010
- Figure 3.2.2.2-2 Geographical distribution of active paracetamol producers in China, 2011
- Figure 3.2.2.4-1 Changes in top 7 export destinations of Chinese paracetamol, 2008-2010, tonnes
- Figure 3.2.3.2-1 Capacity and output of Indian paracetamol, 2007-2010
- Figure 3.2.4.6-1 Forecast on output of Bangladesh's paracetamol, 2011-2015
- Figure 3.2.4.6-2 Forecast on Bangladesh's import of paracetamol from China, 2011-2015
- Figure 3.2.4.6-3 Forecast on domestic consumption of Indonesian paracetamol, 2011-2015
- Figure 3.2.5.5-1 Forecast on domestic consumption of Indonesian paracetamol, 2011-2015
- Figure 3.2.5.5-2 Forecast on Indonesian import of paracetamol from China, 2011-2015
More Asia Manufacturing, Packaging & Detailing Reports
Chemical & Pharmaceutical Plant Construction in Indonesia to 2016: Market Databook by
Timetric
Synopsis Timetric’s, 'Chemical & Pharmaceutical Plant Construction in Indonesia to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical ...
Chemical & Pharmaceutical Plant Construction in Thailand to 2016: Market Databook by
Timetric
Synopsis Timetric’s, 'Chemical & Pharmaceutical Plant Construction in Thailand to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical ...
Chemical & Pharmaceutical Plant Construction in the Philippines to 2016: Market Databook by
Timetric
Synopsis Timetric’s, 'Chemical & Pharmaceutical Plant Construction in the Philippines to 2016: Market Databook' contains detailed historic and forecast market value data for the chemical & ...
Japan Pharma Market Intelligence by
PharmaIntellect
Looking at the great deal of business interest in the Japan Pharmaceutical space, we have recently published a report - "Japan Pharma – Market ...
Oncology Pharmaceuticals Market in India 2012 by
Netscribes (India) Pvt. Ltd.
Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in ...
See all reports like this >>
More Asia Reports
D&B Country RiskLine Report: Vietnam by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country RiskLine Report: Uzbekistan by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country RiskLine Report: Turkmenistan by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country RiskLine Report: Turkey by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country RiskLine Report: Thailand by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
See all reports like this >>
Share this report
Other tasks Related Markets Manufacturing, Packaging & Detailing Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
